| HOME >> MEDICINE >> TECHNOLOGY |
41,04946,795155,466166,629 Adjustments to reconcile net income to net cash from operating activities
10,23513,35339,37849,825 Changes in current assets and liabilities
15,93336,287(47,148)(24,050)Net cash generated from operating activities67,21796,435147,696192,404Cash flow from investing activities: Acquisition cost, net of cash acquired
---(6,530) Capital expenditure
(22,172)(26,207)(65,915)(89,938) (Increase)/decrease in restricted cash
(206)-76,347- Proceeds from sale of restricted/short term investments
9,0277,150100,943100,274 Increase in short term investments and changes in others investing activities
(83,642)(70,940)(298,747)(262,085)Net cash used in investing activities(96,993)(89,997)(187,372)(258,279)Cash flow from financing activities: Repayment of bank loans
145-(169,066)- Proceeds from bank loans
---85,399 Dividend paid
--(22,799)(34,522) Proceeds from exercise of options
1,0051,73011,1607,121 Stock repurchase
-(10,160)-(10,160) Net proceeds from secondary public offering
--149,661- Cash contribution from non-controlling interest
---797Net cash generated from/(used in) financing activities1,150(8,430)(31,044)48,635Net decrease in cash and cash equivalents(28,626)(1,992)(70,720)(17,240)Cash and cash equivalents at beginning of period
164,715124,785204
'/>"/>
| SOURCE Mindray Medical International Limited Copyright©2010 PR Newswire. All rights reserved |